Your browser doesn't support javascript.
loading
Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial.
Pittig, Andre; Heinig, Ingmar; Goerigk, Stephan; Thiel, Freya; Hummel, Katrin; Scholl, Lucie; Deckert, Jürgen; Pauli, Paul; Domschke, Katharina; Lueken, Ulrike; Fydrich, Thomas; Fehm, Lydia; Plag, Jens; Ströhle, Andreas; Kircher, Tilo; Straube, Benjamin; Rief, Winfried; Koelkebeck, Katja; Arolt, Volker; Dannlowski, Udo; Margraf, Jürgen; Totzeck, Christina; Schneider, Silvia; Neudeck, Peter; Craske, Michelle G; Hollandt, Maike; Richter, Jan; Hamm, Alfons; Wittchen, Hans-Ulrich.
Afiliação
  • Pittig A; Department of Psychology (Biological Psychology Clinical Psychology, and Psychotherapy), Center of Mental Health, University of Würzburg, Würzburg, Germany.
  • Heinig I; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Goerigk S; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Thiel F; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Hummel K; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University, Munich, Germany.
  • Scholl L; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Deckert J; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Pauli P; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Domschke K; Department of Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
  • Lueken U; Department of Psychology (Biological Psychology Clinical Psychology, and Psychotherapy), Center of Mental Health, University of Würzburg, Würzburg, Germany.
  • Fydrich T; Department of Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
  • Fehm L; Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Plag J; Center for Basics in NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Ströhle A; Department of Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
  • Kircher T; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Straube B; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rief W; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Koelkebeck K; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Arolt V; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Dannlowski U; Department of Psychiatry and Psychotherapy & Center for Mind Brain and Behavior - CMBB, Philipps-University Marburg, Marburg, Germany.
  • Margraf J; Department of Psychiatry and Psychotherapy & Center for Mind Brain and Behavior - CMBB, Philipps-University Marburg, Marburg, Germany.
  • Totzeck C; Department of Clinical Psychology and Psychotherapy, Faculty of Psychology & Center for Mind, Brain and Behavior - CMBB, Philipps-University of Marburg, Marburg, Germany.
  • Schneider S; Institute for Translational Psychiatry, University of Muenster, Muenster, Germany.
  • Neudeck P; Institute for Translational Psychiatry, University of Muenster, Muenster, Germany.
  • Craske MG; Institute for Translational Psychiatry, University of Muenster, Muenster, Germany.
  • Hollandt M; Mental Health Research and Treatment Center, Ruhr-Universität Bochum, Bochum, Germany.
  • Richter J; Mental Health Research and Treatment Center, Ruhr-Universität Bochum, Bochum, Germany.
  • Hamm A; Mental Health Research and Treatment Center, Ruhr-Universität Bochum, Bochum, Germany.
  • Wittchen HU; Institute of Clinical Psychology & Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Depress Anxiety ; 38(11): 1169-1181, 2021 11.
Article em En | MEDLINE | ID: mdl-34293223
ABSTRACT

BACKGROUND:

The need to optimize exposure treatments for anxiety disorders may be addressed by temporally intensified exposure sessions. Effects on symptom reduction and public health benefits should be examined across different anxiety disorders with comorbid conditions.

METHODS:

This multicenter randomized controlled trial compared two variants of prediction error-based exposure therapy (PeEx) in various anxiety disorders (both 12 sessions + 2 booster sessions, 100 min/session) temporally intensified exposure (PeEx-I) with exposure sessions condensed to 2 weeks (n = 358) and standard nonintensified exposure (PeEx-S) with weekly exposure sessions (n = 368). Primary outcomes were anxiety symptoms (pre, post, and 6-months follow-up). Secondary outcomes were global severity (across sessions), quality of life, disability days, and comorbid depression.

RESULTS:

Both treatments resulted in substantial improvements at post (PeEx-I dwithin = 1.50, PeEx-S dwithin = 1.78) and follow-up (PeEx-I dwithin = 2.34; PeEx-S dwithin = 2.03). Both groups showed formally equivalent symptom reduction at post and follow-up. However, time until response during treatment was 32% shorter in PeEx-I (median = 68 days) than PeEx-S (108 days; TRPeEx-I = 0.68). Interestingly, drop-out rates were lower during intensified exposure. PeEx-I was also superior in reducing disability days and improving quality of life at follow-up without increasing relapse.

CONCLUSIONS:

Both treatment variants focusing on the transdiagnostic exposure-based violation of threat beliefs were effective in reducing symptom severity and disability in severe anxiety disorders. Temporally intensified exposure resulted in faster treatment response with substantial public health benefits and lower drop-out during the exposure phase, without higher relapse. Clinicians can expect better or at least comparable outcomes when delivering exposure in a temporally intensified manner.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Terapia Implosiva Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Terapia Implosiva Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article